BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hilmi M, Bartholin L, Neuzillet C. Immune therapies in pancreatic ductal adenocarcinoma: Where are we now? World J Gastroenterol 2018; 24(20): 2137-2151 [PMID: 29853732 DOI: 10.3748/wjg.v24.i20.2137]
URL: https://www.wjgnet.com/1007-9327/full/v24/i20/2137.htm
Number Citing Articles
1
Martino Maddalena, Giuseppe Mallel, Nishanth Belugali Nataraj, Michal Shreberk-Shaked, Ori Hassin, Saptaparna Mukherjee, Sharathchandra Arandkar, Ron Rotkopf, Abby Kapsack, Giuseppina Lambiase, Bianca Pellegrino, Eyal Ben-Isaac, Ofra Golani, Yoseph Addadi, Emma Hajaj, Raya Eilam, Ravid Straussman, Yosef Yarden, Michal Lotem, Moshe Oren. TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment Proceedings of the National Academy of Sciences 2021; 118(23) doi: 10.1073/pnas.2025631118
2
Saber Amin, Michael Baine, Jane Meza, Chi Lin. The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective analysisBMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07016-8
3
Sijia Tang, Lei Shi, Breona T. Luker, Channen Mickler, Bhavana Suresh, Gregory B. Lesinski, Daping Fan, Yuan Liu, Ming Luo. Modulation of the tumor microenvironment by armed vesicular stomatitis virus in a syngeneic pancreatic cancer modelVirology Journal 2022; 19(1) doi: 10.1186/s12985-022-01757-7
4
Erik B. Faber, Harris B. Krause, Khalid Amin, Philip Walker, Peter J. Hosein, Anthony F. Shields, Heinz-Josef Lenz, Ajay Prakash, Sanjay Goel, Matthew Oberley, Giuseppe Malleo, Claudio Luchini, Justin Hwang, Vaia Florou, Ignacio Garrido‐Laguna, Emil Lou. Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of Pancreatic Carcinomas: In Search of Therapeutic TargetsJCO Precision Oncology 2024; (8) doi: 10.1200/PO.23.00595
5
Xiaochuan Hu, Guoyi Ke, Sophia R.-J. Jang. Modeling Pancreatic Cancer Dynamics with ImmunotherapyBulletin of Mathematical Biology 2019; 81(6): 1885 doi: 10.1007/s11538-019-00591-3
6
Andrew J. Gunderson, Venkatesh Rajamanickam, Cynthia Bui, Brady Bernard, Joanna Pucilowska, Carmen Ballesteros-Merino, Mark Schmidt, Kayla McCarty, Michaela Philips, Brian Piening, Christopher Dubay, Terry Medler, Phillipa Newell, Paul Hansen, Eric Tran, Ephraim Tang, Carlo Bifulco, Marka Crittenden, Michael Gough, Kristina H. Young. Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancerOncoImmunology 2021; 10(1) doi: 10.1080/2162402X.2021.1900635
7
Zhengting Jiang, Wenjie Zhang, Zhilin Zhang, Gengyu Sha, Daorong Wang, Dong Tang. Intratumoral microbiota: A new force in diagnosing and treating pancreatic cancerCancer Letters 2023; 554: 216031 doi: 10.1016/j.canlet.2022.216031
8
Donatella Delle Cave, Riccardo Rizzo, Bruno Sainz, Giuseppe Gigli, Loretta L. del Mercato, Enza Lonardo. The Revolutionary Roads to Study Cell–Cell Interactions in 3D In Vitro Pancreatic Cancer ModelsCancers 2021; 13(4): 930 doi: 10.3390/cancers13040930
9
Hsuan‐Chen Liu, Daniel Davila Gonzalez, Dixita Ishani Viswanath, Robin Shae Vander Pol, Shani Zakiya Saunders, Nicola Di Trani, Yitian Xu, Junjun Zheng, Shu‐Hsia Chen, Corrine Ying Xuan Chua, Alessandro Grattoni. Sustained Intratumoral Administration of Agonist CD40 Antibody Overcomes Immunosuppressive Tumor Microenvironment in Pancreatic CancerAdvanced Science 2023; 10(9) doi: 10.1002/advs.202206873
10
Amalia Azzariti, Rosa Maria Iacobazzi, Roberta Di Fonte, Letizia Porcelli, Roberto Gristina, Pietro Favia, Francesco Fracassi, Ilaria Trizio, Nicola Silvestris, Gabriella Guida, Stefania Tommasi, Eloisa Sardella. Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cellsScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-40637-z
11
Shivani Malik, Jill M. Westcott, Rolf A. Brekken, Francis J. Burrows. CXCL12 in Pancreatic Cancer: Its Function and Potential as a Therapeutic Drug TargetCancers 2021; 14(1): 86 doi: 10.3390/cancers14010086
12
Michael Guenther, Vivien Veninga, Joerg Kumbrink, Michael Haas, C. Benedikt Westphalen, Stephan Kruger, Volker Heinemann, Thomas Kirchner, Stefan Boeck, Andreas Jung, Steffen Ormanns. POLE gene hotspot mutations in advanced pancreatic cancerJournal of Cancer Research and Clinical Oncology 2018; 144(11): 2161 doi: 10.1007/s00432-018-2746-x
13
Mark R Sullivan, Laura V Danai, Caroline A Lewis, Sze Ham Chan, Dan Y Gui, Tenzin Kunchok, Emily A Dennstedt, Matthew G Vander Heiden, Alexander Muir. Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availabilityeLife 2019; 8 doi: 10.7554/eLife.44235
14
Saber Amin, Chi Lin. Immunotherapy Plus Chemoradiation Improves Overall Survival in Stage IV Esophageal Cancer: A Cohort StudyGastro Hep Advances 2024; 3(3): 302 doi: 10.1016/j.gastha.2023.12.004
15
Jaroslaw Daniluk, Urszula Daniluk, Pawel Rogalski, Andrzej Dabrowski, Agnieszka Swidnicka-Siergiejko. Microbiome—Friend or Foe of Pancreatic Cancer?Journal of Clinical Medicine 2021; 10(23): 5624 doi: 10.3390/jcm10235624
16
Chin-King Looi, Felicia Fei-Lei Chung, Chee-Onn Leong, Shew-Fung Wong, Rozita Rosli, Chun-Wai Mai. Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironmentJournal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1153-8
17
Mengjiao Fan, Yue Ma, Guochao Deng, Haiyan Si, Ru Jia, Zhikuan Wang, Guanghai Dai. A real-world analysis of second-line treatment option, Gemcitabine plus Anlotinib and anti-PD1, in advanced pancreatic cancerPancreatology 2024;  doi: 10.1016/j.pan.2024.03.017
18
Pascal Hammel, Carole Vitellius, Émeric Boisteau, Mathilde Wisniewski, Elise Colle, Marc Hilmi, Christelle Dengremont, Sandra Granier, Anthony Turpin, Louis de Mestier, Cindy Neuzillet. Maintenance therapies in metastatic pancreatic cancer: present and future with a focus on PARP inhibitorsTherapeutic Advances in Medical Oncology 2020; 12: 175883592093794 doi: 10.1177/1758835920937949
19
Rami Alzhrani, Hashem O. Alsaab, Kushal Vanamala, Ketki Bhise, Katyayani Tatiparti, Ayatakshi Barari, Samaresh Sau, Arun K. Iyer. Overcoming the Tumor Microenvironmental Barriers of Pancreatic Ductal Adenocarcinomas for Achieving Better Treatment OutcomesAdvanced Therapeutics 2021; 4(6) doi: 10.1002/adtp.202000262
20
Roberto Salvia, Fabio Casciani, Elisabetta Sereni, Claudio Bassi. Pancreatic cancer – What's next?La Presse Médicale 2019; 48(3): e187 doi: 10.1016/j.lpm.2019.02.031
21
Roland Andersson, Carlos-Filipe Pereira, Monika Bauden, Daniel Ansari. Is Immunotherapy the Holy Grail for Pancreatic Cancer?Immunotherapy 2019; 11(17): 1435 doi: 10.2217/imt-2019-0164
22
Cindy Neuzillet, Rémy Nicolle, Jérôme Raffenne, Annemilaï Tijeras‐Raballand, Alexia Brunel, Lucile Astorgues‐Xerri, Sophie Vacher, Floriane Arbateraz, Marjorie Fanjul, Marc Hilmi, Rémi Samain, Christophe Klein, Aurélie Perraud, Vinciane Rebours, Muriel Mathonnet, Ivan Bièche, Hemant Kocher, Jérôme Cros, Corinne Bousquet. Periostin‐ and podoplanin‐positive cancer‐associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinomaThe Journal of Pathology 2022; 258(4): 408 doi: 10.1002/path.6011
23
Marie Muller, Vincent Haghnejad, Marion Schaefer, Guillaume Gauchotte, Bénédicte Caron, Laurent Peyrin-Biroulet, Jean-Pierre Bronowicki, Cindy Neuzillet, Anthony Lopez. The Immune Landscape of Human Pancreatic Ductal Carcinoma: Key Players, Clinical Implications, and ChallengesCancers 2022; 14(4): 995 doi: 10.3390/cancers14040995
24
Jinthe Van Loenhout, Tal Flieswasser, Laurie Freire Boullosa, Jorrit De Waele, Jonas Van Audenaerde, Elly Marcq, Julie Jacobs, Abraham Lin, Eva Lion, Heleen Dewitte, Marc Peeters, Sylvia Dewilde, Filip Lardon, Annemie Bogaerts, Christophe Deben, Evelien Smits. Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer CellsCancers 2019; 11(10): 1597 doi: 10.3390/cancers11101597
25
Marc Hilmi, Angélique Vienot, Benoît Rousseau, Cindy Neuzillet. Immune Therapy for Liver CancersCancers 2019; 12(1): 77 doi: 10.3390/cancers12010077
26
Daoan Cheng, Jing Hu, Xiaoyu Wu, Banglu Wang, Rui Chen, Weiqing Zhao, Cheng Fang, Mei Ji. PD-1 blockade combined with gemcitabine plus nab-paclitaxel is superior to chemotherapy alone in the management of unresectable stage III/IV pancreatic cancer: a retrospective real-world studyFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1281545
27
Jonathan J. Hue, Katherine Bingmer, Kavin Sugumar, Sarah C. Markt, Luke D. Rothermel, Jeffrey M. Hardacre, John B. Ammori, Jordan M. Winter, Lee M. Ocuin. Immunotherapy Is Associated with a Survival Benefit in Patients Receiving Chemotherapy for Metastatic Pancreatic CancerJournal of Pancreatic Cancer 2021; 7(1): 31 doi: 10.1089/pancan.2021.0003
28
Claudia C. Preston, Randolph S. Faustino. Nuclear Envelope Regulation of Oncogenic Processes: Roles in Pancreatic CancerEpigenomes 2018; 2(3): 15 doi: 10.3390/epigenomes2030015
29
Glancis Luzeena Raja Arul, Merih D. Toruner, Robert A. Gatenby, Ryan M. Carr. Ecoevolutionary biology of pancreatic ductal adenocarcinomaPancreatology 2022; 22(6): 730 doi: 10.1016/j.pan.2022.06.005
30
Ghazaleh Pourali, Nima Zafari, Mahla Velayati, Shima Mehrabadi, Mina Maftooh, Seyed Mahdi Hassanian, Majid Ghayour Mobarhan, Gordon A. Ferns, Amir Avan, Majid Khazaei. Therapeutic Potential of Targeting Transforming Growth Factor-beta (TGF-β) and Programmed Death-ligand 1 (PD-L1) in Pancreatic CancerCurrent Drug Targets 2023; 24(17): 1335 doi: 10.2174/0113894501264450231129042256
31
Yi Huang, Ping Gong, Li Su, Mei Zhang. Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinomaScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-47223-4
32
Nicholas Osborne, Rebecca Sundseth, Julian Burks, Hong Cao, Xunxian Liu, Alexander H. Kroemer, Lynda Sutton, Allen Cato, Jill P. Smith. Gastrin vaccine improves response to immune checkpoint antibody in murine pancreatic cancer by altering the tumor microenvironmentCancer Immunology, Immunotherapy 2019; 68(10): 1635 doi: 10.1007/s00262-019-02398-6
33
L.C. Cutmore, N.F. Brown, D. Raj, S. Chauduri, P. Wang, J. Maher, Y. Wang, N.R. Lemoine, J.F. Marshall. Pancreatic Cancer UK Grand Challenge: Developments and challenges for effective CAR T cell therapy for pancreatic ductal adenocarcinomaPancreatology 2020; 20(3): 394 doi: 10.1016/j.pan.2020.02.006
34
Saber Amin, Michael Baine, Jane Meza, Morshed Alam, Chi Lin. The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who received definitive surgery of the pancreatic tumor: a retrospective analysis of the National Cancer DatabaseRadiation Oncology 2020; 15(1) doi: 10.1186/s13014-020-01569-5
35
Marc Hilmi, Matthieu Delaye, Milena Muzzolini, Rémy Nicolle, Jérôme Cros, Pascal Hammel, Victoire Cardot-Ruffino, Cindy Neuzillet. The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapyThe Lancet Gastroenterology & Hepatology 2023; 8(12): 1129 doi: 10.1016/S2468-1253(23)00207-8
36
Alexandros Bokas, Pavlos Papakotoulas, Panagiotis Sarantis, Adriana Papadimitropoulou, Athanasios G Papavassiliou, Michalis V Karamouzis. Mechanisms of the Antitumor Activity of Low Molecular Weight Heparins in Pancreatic AdenocarcinomasCancers 2020; 12(2): 432 doi: 10.3390/cancers12020432
37
Purushottam Lamichhane, Rahul Deshmukh, Julie Brown, Silvia Jakubski, Priyanka Parajuli, Todd Nolan, Dewan Raja, Mary Badawy, Thomas Yoon, Mark Zmiyiwsky, Narottam Lamichhane. Novel Delivery Systems for Checkpoint InhibitorsMedicines 2019; 6(3): 74 doi: 10.3390/medicines6030074
38
S. Ormanns. Personalisierte KrebsmedizinDer Pathologe 2018; 39(S2): 221 doi: 10.1007/s00292-018-0539-2
39
Jia Wu, Jianting Cai. Dilemma and Challenge of Immunotherapy for Pancreatic CancerDigestive Diseases and Sciences 2021; 66(2): 359 doi: 10.1007/s10620-020-06183-9
40
Sara De Dosso, Alexander R. Siebenhüner, Thomas Winder, Alexander Meisel, Ralph Fritsch, Christoforos Astaras, Petr Szturz, Markus Borner. Treatment landscape of metastatic pancreatic cancerCancer Treatment Reviews 2021; 96: 102180 doi: 10.1016/j.ctrv.2021.102180
41
Luisa Barrueto, Francheska Caminero, Lindsay Cash, Courtney Makris, Purushottam Lamichhane, Rahul R. Deshmukh. Resistance to Checkpoint Inhibition in Cancer ImmunotherapyTranslational Oncology 2020; 13(3): 100738 doi: 10.1016/j.tranon.2019.12.010
42
Elodie Roger, Sylvie Martel, Adrien Bertrand-Chapel, Arnaud Depollier, Nicolas Chuvin, Roxane M. Pommier, Karam Yacoub, Cassandre Caligaris, Victoire Cardot-Ruffino, Véronique Chauvet, Sophie Aires, Kayvan Mohkam, Jean-Yves Mabrut, Mustapha Adham, Tanguy Fenouil, Valérie Hervieu, Laura Broutier, Marie Castets, Cindy Neuzillet, Philippe A. Cassier, Richard Tomasini, Stéphanie Sentis, Laurent Bartholin. Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signalingCell Death & Disease 2019; 10(12) doi: 10.1038/s41419-019-2116-x
43
Nathalia Ferreira, Ajinkya Kulkarni, David Agorku, Teona Midelashvili, Olaf Hardt, Tobias J. Legler, Philipp Ströbel, Lena-Christin Conradi, Frauke Alves, Fernanda Ramos-Gomes, M. Andrea Markus. OrganoIDNet: a deep learning tool for identification of therapeutic effects in PDAC organoid-PBMC co-cultures from time-resolved imaging dataCellular Oncology 2024;  doi: 10.1007/s13402-024-00958-2
44
Jin-Yu Sun, Dengke Zhang, Songquan Wu, Min Xu, Xiao Zhou, Xiao-Jie Lu, Jiansong Ji. Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectivesBiomarker Research 2020; 8(1) doi: 10.1186/s40364-020-00212-5
45
Leonie Enderle, Karim H. Shalaby, Maryna Gorelik, Alexander Weiss, Levi L. Blazer, Marcin Paduch, Lia Cardarelli, Anthony Kossiakoff, Jarrett J. Adams, Sachdev S. Sidhu. A T cell redirection platform for co-targeting dual antigens on solid tumorsmAbs 2021; 13(1) doi: 10.1080/19420862.2021.1933690
46
E.B. Faber, Y. Baca, J. Xiu, P. Walker, G. Manji, S. Gholami, A. Saeed, A. Prakash, G.P. Botta, D. Sohal, H.J. Lenz, A.F. Shields, C. Nabhan, W. El-Deiry, A. Seeber, V. Chiu, J. Hwang, E. Lou. Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to KRAS mutational statusESMO Gastrointestinal Oncology 2024; 4: 100042 doi: 10.1016/j.esmogo.2024.100042
47
Deeksha G Lahori, Pegah Varamini. Nanotechnology-Based Platforms to Improve Immune Checkpoint Blockade Efficacy in Cancer TherapyFuture Oncology 2021; 17(6): 711 doi: 10.2217/fon-2020-0720
48
Tianyi Zhang, Yanxian Ren, Pengfei Yang, Jufang Wang, Heng Zhou. Cancer-associated fibroblasts in pancreatic ductal adenocarcinomaCell Death & Disease 2022; 13(10) doi: 10.1038/s41419-022-05351-1
49
Rannah Dabiri, Mamoon Ur Rashid, Osama Sherjeel Khan, Sundas Jehanzeb, Mohammad Alomari, Hammad Zafar, Effa Zahid, Asad Ur Rahman, Alvina Karam, Sarfraz Ahmad. Immune Landscape of Pancreatic Cancer Development and Drug Resistance2024; : 103 doi: 10.1016/B978-0-443-23523-8.00021-3
50
Nadine Sperb, Miltiadis Tsesmelis, Thomas Wirth. Crosstalk between Tumor and Stromal Cells in Pancreatic Ductal AdenocarcinomaInternational Journal of Molecular Sciences 2020; 21(15): 5486 doi: 10.3390/ijms21155486
51
Yueze Liu, Mengyu Feng, Hao Chen, Gang Yang, Jiangdong Qiu, Fangyu Zhao, Zhe Cao, Wenhao Luo, Jianchun Xiao, Lei You, Lianfang Zheng, Taiping Zhang. Mechanistic target of rapamycin in the tumor microenvironment and its potential as a therapeutic target for pancreatic cancerCancer Letters 2020; 485: 1 doi: 10.1016/j.canlet.2020.05.003
52
Matias Estaras, Antonio Gonzalez. Modulation of cell physiology under hypoxia in pancreatic cancerWorld Journal of Gastroenterology 2021; 27(28): 4582-4602 doi: 10.3748/wjg.v27.i28.4582
53
Anthony Turpin, Cindy Neuzillet, Elise Colle, Nelson Dusetti, Rémy Nicolle, Jérôme Cros, Louis de Mestier, Jean-Baptiste Bachet, Pascal Hammel. Therapeutic advances in metastatic pancreatic cancer: a focus on targeted therapiesTherapeutic Advances in Medical Oncology 2022; 14: 175883592211180 doi: 10.1177/17588359221118019
54
J. Fréderique de Graaf, Marco Huberts, Daphne Groeneveld, Stefan van Nieuwkoop, Casper H.J. van Eijck, Ron A.M. Fouchier, Bernadette G. van den Hoogen. Comparison between intratumoral and intravenously administered oncolytic virus therapy with Newcastle disease virus in a xenograft murine model for pancreatic adenocarcinomaHeliyon 2022; 8(7): e09915 doi: 10.1016/j.heliyon.2022.e09915
55
Fabienne Maibach, Hassan Sadozai, S. Morteza Seyed Jafari, Robert E. Hunger, Mirjam Schenk. Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous MelanomaFrontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.02105
56
Max Piffoux, Erwan Eriau, Philippe A. Cassier. Autophagy as a therapeutic target in pancreatic cancerBritish Journal of Cancer 2021; 124(2): 333 doi: 10.1038/s41416-020-01039-5
57
Anna Silvia Wenning, Christoph O. Ryser, Andreas Andreou, Beat Gloor, Martin D. Berger. Neues zur Therapie des Pankreaskarzinoms: Hoffnung am Horizont?Schweizer Gastroenterologie 2021; 2(4): 138 doi: 10.1007/s43472-021-00054-y
58
Sathish Kumar Mungamuri, Anil Kumar Pasupulati, Vijay Aditya Mavuduru. Exploring Pancreatic Metabolism and Malignancy2019; : 215 doi: 10.1007/978-981-32-9393-9_13
59
Kanan Panchal, Rakesh Kumar Sahoo, Umesh Gupta, Akash Chaurasiya. Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overviewInternational Immunopharmacology 2021; 95: 107508 doi: 10.1016/j.intimp.2021.107508
60
Davide Melisi, Do-Youn Oh, Antoine Hollebecque, Emiliano Calvo, Anna Varghese, Erkut Borazanci, Teresa Macarulla, Valeria Merz, Camilla Zecchetto, Yumin Zhao, Ivelina Gueorguieva, Michael Man, Leena Gandhi, Shawn T Estrem, Karim A Benhadji, Mark C Lanasa, Emin Avsar, Susan C Guba, Rocio Garcia-Carbonero. Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancerJournal for ImmunoTherapy of Cancer 2021; 9(3): e002068 doi: 10.1136/jitc-2020-002068
61
Abhinav V. Reddy, Colin S. Hill, Shuchi Sehgal, Lei Zheng, Jin He, Daniel A. Laheru, Ana De Jesus-Acosta, Joseph M. Herman, Jeffrey Meyer, Amol K. Narang. Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapyRadiation Oncology Journal 2022; 40(2): 111 doi: 10.3857/roj.2021.01060
62
Jiali Du, Jichun Gu, Ji Li. Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levelsBioscience Reports 2020; 40(7) doi: 10.1042/BSR20200401
63
Purushottam Lamichhane, Neha P. Amin, Manuj Agarwal, Narottam Lamichhane. Checkpoint Inhibition: Will Combination with Radiotherapy and Nanoparticle-Mediated Delivery Improve Efficacy?Medicines 2018; 5(4): 114 doi: 10.3390/medicines5040114
64
Dushyant Singh Dahiya, Asim Kichloo, Jagmeet Singh, Michael Albosta, Manidhar Lekkala. Current Immunotherapy in Gastrointestinal Malignancies a ReviewJournal of Investigative Medicine 2021; 69(3): 689 doi: 10.1136/jim-2020-001654
65
Michael F. Coleman, Kristyn A. Liu, Alexander J. Pfeil, Suhas K. Etigunta, Xiaohu Tang, Salvador Fabela, Laura M. Lashinger, Zhengrong Cui, Stephen D. Hursting. β-Hydroxy-β-Methylbutyrate Supplementation Promotes Antitumor Immunity in an Obesity Responsive Mouse Model of Pancreatic Ductal AdenocarcinomaCancers 2021; 13(24): 6359 doi: 10.3390/cancers13246359
66
Aline Barhli, Jérôme Cros, Laurent Bartholin, Cindy Neuzillet. Prognostic stratification of resected pancreatic ductal adenocarcinoma: Past, present, and futureDigestive and Liver Disease 2018; 50(10): 979 doi: 10.1016/j.dld.2018.08.009
67
Chenyang Li, Baoyi Zhang, Evelien Schaafsma, Alexandre Reuben, Linghua Wang, Mary Jo Turk, Jianjun Zhang, Chao Cheng. TimiGP: Inferring cell-cell interactions and prognostic associations in the tumor immune microenvironment through gene pairsCell Reports Medicine 2023; 4(7): 101121 doi: 10.1016/j.xcrm.2023.101121
68
Sofie Olsson Hau, Sara Wahlin, Sophie Cervin, Vilgot Falk, Björn Nodin, Jacob Elebro, Jakob Eberhard, Bruce Moran, William M Gallagher, Emelie Karnevi, Karin Jirström. PRR11 unveiled as a top candidate biomarker within the RBM3‐regulated transcriptome in pancreatic cancerThe Journal of Pathology: Clinical Research 2022; 8(1): 65 doi: 10.1002/cjp2.238
69
Qi Zhou, Xufeng Tao, Shilin Xia, Fangyue Guo, Chen Pan, Hong Xiang, Dong Shang. T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00382
70
Annemilaï Tijeras-Raballand, Marc Hilmi, Lucile Astorgues-Xerri, Rémy Nicolle, Ivan Bièche, Cindy Neuzillet. Microbiome and pancreatic ductal adenocarcinomaClinics and Research in Hepatology and Gastroenterology 2021; 45(2): 101589 doi: 10.1016/j.clinre.2020.101589
71
Luis Guilherme de Oliveira Silva, Fabian Fellipe Bueno Lemos, Marcel Silva Luz, Samuel Luca Rocha Pinheiro, Mariana dos Santos Calmon, Gabriel Lima Correa Santos, Gabriel Reis Rocha, Fabrício Freire de Melo. New avenues for the treatment of immunotherapy-resistant pancreatic cancerWorld Journal of Gastrointestinal Oncology 2024; 16(4): 1134-1153 doi: 10.4251/wjgo.v16.i4.1134
72
Panagiotis Sarantis, Evangelos Koustas, Adriana Papadimitropoulou, Athanasios G Papavassiliou, Michalis V Karamouzis. Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapyWorld Journal of Gastrointestinal Oncology 2020; 12(2): 173-181 doi: 10.4251/wjgo.v12.i2.173
73
Shailendra K. Gautam, Sushil Kumar, Vi Dam, Dario Ghersi, Maneesh Jain, Surinder K. Batra. MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapySeminars in Immunology 2020; 47: 101391 doi: 10.1016/j.smim.2020.101391
74
Zev A. Wainberg, Howard S. Hochster, Edward J. Kim, Ben George, Aparna Kaylan, E. Gabriela Chiorean, David M. Waterhouse, Martin Guiterrez, Aparna Parikh, Rishi Jain, Daniel Ricardo Carrizosa, Hatem H. Soliman, Thomas Lila, David J. Reiss, Daniel W. Pierce, Rafia Bhore, Sibabrata Banerjee, Larry Lyons, Chrystal U. Louis, Teng Jin Ong, Peter J. O'Dwyer. Open-label, Phase I Study of Nivolumab Combined with nab-Paclitaxel Plus Gemcitabine in Advanced Pancreatic CancerClinical Cancer Research 2020; 26(18): 4814 doi: 10.1158/1078-0432.CCR-20-0099
75
Qian Zhang, Liping Lv, Ping Ma, Yangyang Zhang, Jiang Deng, Yanyu Zhang. Identification of an Autophagy-Related Pair Signature for Predicting Prognoses and Immune Activity in Pancreatic AdenocarcinomaFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.743938
76
Mengni Chen, Shengli Yang, Li Fan, Lu Wu, Renwang Chen, Jian Chang, Jianli Hu. Combined Antiangiogenic Therapy and Immunotherapy Is Effective for Pancreatic Cancer With Mismatch Repair Proficiency but High Tumor Mutation BurdenPancreas 2019; 48(9): 1232 doi: 10.1097/MPA.0000000000001398
77
Clara S. Mundry, Kirsten C. Eberle, Pankaj K. Singh, Michael A. Hollingsworth, Kamiya Mehla. Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor’s arsenalBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(1): 188387 doi: 10.1016/j.bbcan.2020.188387
78
Chenfei Zhou, Jun Zhang. Immunotherapy-based combination strategies for treatment of gastrointestinal cancers: current status and future prospectsFrontiers of Medicine 2019; 13(1): 12 doi: 10.1007/s11684-019-0685-9
79
Didem Saka, Muazzez Gökalp, Betül Piyade, Nedim Can Cevik, Elif Arik Sever, Derya Unutmaz, Güralp O. Ceyhan, Ihsan Ekin Demir, Hande Asimgil. Mechanisms of T-Cell Exhaustion in Pancreatic CancerCancers 2020; 12(8): 2274 doi: 10.3390/cancers12082274
80
Evelyne Tassone, Michela Muscolini, Nadine van Montfoort, John Hiscott. Oncolytic virotherapy for pancreatic ductal adenocarcinoma: A glimmer of hope after years of disappointment?Cytokine & Growth Factor Reviews 2020; 56: 141 doi: 10.1016/j.cytogfr.2020.07.015
81
Daniel C. Osei-Bordom, Nikolaos Serifis, Zachary J. Brown, D. Brock Hewitt, Gbemisola Lawal, Gagandeep Sachdeva, Daniel J. Cloonan, Timothy M. Pawlik. Pancreatic ductal adenocarcinoma: Emerging therapeutic strategiesSurgical Oncology 2022; 43: 101803 doi: 10.1016/j.suronc.2022.101803
82
Xiaoyu Guo, Pan Wang, Yuan Li, Yawei Chang, Xiaobing Wang. Microbiomes in pancreatic cancer can be an accomplice or a weaponCritical Reviews in Oncology/Hematology 2024; 194: 104262 doi: 10.1016/j.critrevonc.2024.104262
83
Prashant Dogra, Javier R. Ramírez, María J. Peláez, Zhihui Wang, Vittorio Cristini, Gulshan Parasher, Manmeet Rawat. Mathematical Modeling to Address Challenges in Pancreatic CancerCurrent Topics in Medicinal Chemistry 2020; 20(5): 367 doi: 10.2174/1568026620666200101095641
84
Shuping Si, Lei Wang, Hui Cao, Yuhua Xu, Qiang Zhan. Co-deficiency of B7-H3 and B7-H4 identifies high CD8 + T cell infiltration and better prognosis in pancreatic cancerBMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09294-w
85
Ana Raquel Bastos, Joana Pereira-Marques, Rui Manuel Ferreira, Ceu Figueiredo. Harnessing the Microbiome to Reduce Pancreatic Cancer BurdenCancers 2023; 15(9): 2629 doi: 10.3390/cancers15092629
86
Caleb R. Stoltzfus, Ramya Sivakumar, Leo Kunz, Brandy E. Olin Pope, Elena Menietti, Dario Speziale, Roberto Adelfio, Marina Bacac, Sara Colombetti, Mario Perro, Michael Y. Gerner. Multi-Parameter Quantitative Imaging of Tumor Microenvironments Reveals Perivascular Immune Niches Associated With Anti-Tumor ImmunityFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.726492
87
Liwei Cao, Chen Huang, Daniel Cui Zhou, Yingwei Hu, T. Mamie Lih, Sara R. Savage, Karsten Krug, David J. Clark, Michael Schnaubelt, Lijun Chen, Felipe da Veiga Leprevost, Rodrigo Vargas Eguez, Weiming Yang, Jianbo Pan, Bo Wen, Yongchao Dou, Wen Jiang, Yuxing Liao, Zhiao Shi, Nadezhda V. Terekhanova, Song Cao, Rita Jui-Hsien Lu, Yize Li, Ruiyang Liu, Houxiang Zhu, Peter Ronning, Yige Wu, Matthew A. Wyczalkowski, Hariharan Easwaran, Ludmila Danilova, Arvind Singh Mer, Seungyeul Yoo, Joshua M. Wang, Wenke Liu, Benjamin Haibe-Kains, Mathangi Thiagarajan, Scott D. Jewell, Galen Hostetter, Chelsea J. Newton, Qing Kay Li, Michael H. Roehrl, David Fenyö, Pei Wang, Alexey I. Nesvizhskii, D.R. Mani, Gilbert S. Omenn, Emily S. Boja, Mehdi Mesri, Ana I. Robles, Henry Rodriguez, Oliver F. Bathe, Daniel W. Chan, Ralph H. Hruban, Li Ding, Bing Zhang, Hui Zhang, Mitual Amin, Eunkyung An, Christina Ayad, Thomas Bauer, Chet Birger, Michael J. Birrer, Simina M. Boca, William Bocik, Melissa Borucki, Shuang Cai, Steven A. Carr, Sandra Cerda, Huan Chen, Steven Chen, David Chesla, Arul M. Chinnaiyan, Antonio Colaprico, Sandra Cottingham, Magdalena Derejska, Saravana M. Dhanasekaran, Marcin J. Domagalski, Brian J. Druker, Elizabeth Duffy, Maureen A. Dyer, Nathan J. Edwards, Matthew J. Ellis, Jennifer Eschbacher, Alicia Francis, Jesse Francis, Stacey Gabriel, Nikolay Gabrovski, Johanna Gardner, Gad Getz, Michael A. Gillette, Charles A. Goldthwaite, Pamela Grady, Shuai Guo, Pushpa Hariharan, Tara Hiltke, Barbara Hindenach, Katherine A. Hoadley, Jasmine Huang, Corbin D. Jones, Karen A. Ketchum, Christopher R. Kinsinger, Jennifer M. Koziak, Katarzyna Kusnierz, Tao Liu, Jiang Long, David Mallery, Sailaja Mareedu, Ronald Matteotti, Nicollette Maunganidze, Peter B. McGarvey, Parham Minoo, Oxana V. Paklina, Amanda G. Paulovich, Samuel H. Payne, Olga Potapova, Barbara Pruetz, Liqun Qi, Nancy Roche, Karin D. Rodland, Daniel C. Rohrer, Eric E. Schadt, Alexey V. Shabunin, Troy Shelton, Yvonne Shutack, Shilpi Singh, Michael Smith, Richard D. Smith, Lori J. Sokoll, James Suh, Ratna R. Thangudu, Shirley X. Tsang, Ki Sung Um, Dana R. Valley, Negin Vatanian, Wenyi Wang, George D. Wilson, Maciej Wiznerowicz, Zhen Zhang, Grace Zhao. Proteogenomic characterization of pancreatic ductal adenocarcinomaCell 2021; 184(19): 5031 doi: 10.1016/j.cell.2021.08.023
88
Sushmitha Sankarasubramanian, Ulrike Pfohl, Christian R. A. Regenbrecht, Christoph Reinhard, Lena Wedeken. Context Matters—Why We Need to Change From a One Size Fits all Approach to Made-to-Measure Therapies for Individual Patients With Pancreatic CancerFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.760705
89
Lishan Fang, Shaojing Chen, Hui Gong, Shaohua Xia, Sainan Guan, Nali Quan, Yajie Li, Chao Zeng, Ya Chen, Jianhang Du, Shuguang Liu. Identification of an unfolded protein response-related signature for predicting the prognosis of pancreatic ductal adenocarcinomaFrontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1060508
90
Christopher Montemagno, Shamir Cassim, Jacques Pouyssegur, Alexis Broisat, Gilles Pagès. From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal AdenocarcinomaInternational Journal of Molecular Sciences 2020; 21(11): 4067 doi: 10.3390/ijms21114067
91
Juan J Apiz Saab, Lindsey N Dzierozynski, Patrick B Jonker, Roya AminiTabrizi, Hardik Shah, Rosa Elena Menjivar, Andrew J Scott, Zeribe C Nwosu, Zhou Zhu, Riona N Chen, Moses Oh, Colin Sheehan, Daniel R Wahl, Marina Pasca di Magliano, Costas A Lyssiotis, Kay F Macleod, Christopher R Weber, Alexander Muir. Pancreatic tumors exhibit myeloid-driven amino acid stress and upregulate arginine biosynthesiseLife 2023; 12 doi: 10.7554/eLife.81289
92
Paloma E. Garcia, Michael K. Scales, Benjamin L. Allen, Marina Pasca di Magliano. Pancreatic Fibroblast Heterogeneity: From Development to CancerCells 2020; 9(11): 2464 doi: 10.3390/cells9112464
93
Dafeng Xu, Yu Wang, Yonghai Chen, Jinfang Zheng. Identification of the molecular subtype and prognostic characteristics of pancreatic cancer based on CD8 + T cell-related genesCancer Immunology, Immunotherapy 2023; 72(3): 647 doi: 10.1007/s00262-022-03269-3